Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
World Stock Market Benchmarks summarize how major markets compare. This brief intro explains the benchmarks, the indices involved, and how investors use them to gauge global performance.
28,358 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Signet Jewelers is not just selling rings anymore. A pivot to lab-grown diamonds is reshaping growth and margins. Thi...
When the market's fear gauge just spiked, investors wonder what comes next for AI stocks. This guide breaks down the ...
A high-profile insider move at Navan has investors weighing the stock. This guide breaks down what navan's chief acco...
Rocket Lab stock has hit an all-time high, but savvy investors know a rally is more than a headline. This guide break...
Rocket Lab isn’t profitable yet, but the space company shows four clear catalysts for investors. Here are practical r...
Micron investors are bracing for a pivotal June 24 earnings report. This guide explains the drivers, possible outcome...
Want to know if Bristol Myers Squibb is worth a spot in your portfolio? This deep dive highlights three core reasons ...
AI is reshaping how we power and cool data centers, not just how we drive cars. This article highlights an under-the-...
Numbers matter, but stories move markets. This guide explains why narratives matter for stock prices and how investor...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...